Antigen-specific T cells CART/CTL and DCvac ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 34 | 神経線維腫症 | 1 |
34. 神経線維腫症
臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04085159 (ClinicalTrials.gov) | September 1, 2019 | 9/9/2019 | Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis | Immunotherapy Targeting Neurofibromatosis or Schwannomatosis | Cancer | Biological: Antigen-specific T cells CART/CTL and DCvac | Shenzhen Geno-Immune Medical Institute | Shenzhen Hospital of Southern Medical University;Shenzhen Children's Hospital | Recruiting | 1 Year | 80 Years | All | 100 | Phase 1/Phase 2 | China |